News and press releases
Stay up to date with the Association’s news and events.
Quick links
Press releases
PPTA statements
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Feb 14, 2023
PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation
The Plasma Protein Therapeutics Association (PPTA) welcomes the call in the draft report on the European Commission's proposal for a Regulation on the Standards of quality and safety for substances of human origin (SoHO) by European Parliament rapporteur MEP Nathalie Colin-Oesterlé to reach higher strategic autonomy for plasma supply for the manufacturing of plasma-derived medicinal products (PDMPs).
All
PPTA statements
Feb 14, 2023
PPTA Statement on Report of ENVI Rapporteur for the SoHO Regulation
The Plasma Protein Therapeutics Association (PPTA) welcomes the call in the draft report on the European Commission's proposal for a Regulation on the Standards of quality and safety for substances of human origin (SoHO) by European Parliament rapporteur MEP Nathalie Colin-Oesterlé to reach higher strategic autonomy for plasma supply for the manufacturing of plasma-derived medicinal products (PDMPs).
All
PPTA statements
Oct 3, 2022
International Plasma Awareness Week 2022: Donate Locally. Think Globally.
ANNAPOLIS, MD (October 3, 2022) — The Plasma Protein Therapeutics Association (PPTA) is proud to mark the launch of the 10th annual International Plasma Awareness Week (IPAW), which will run from Monday, October 3 until Friday, October 7.
All
Press releases
Oct 3, 2022
International Plasma Awareness Week 2022: Donate Locally. Think Globally.
ANNAPOLIS, MD (October 3, 2022) — The Plasma Protein Therapeutics Association (PPTA) is proud to mark the launch of the 10th annual International Plasma Awareness Week (IPAW), which will run from Monday, October 3 until Friday, October 7.
All
Press releases
Jul 14, 2022
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA welcomes positive developments but regrets missed opportunities to support plasma donors and patients who rely on plasma-derived medicinal products (PDMPs)
All
PPTA statements
Jul 14, 2022
PPTA Statement on the draft EU Substances of Human Origin Regulation
PPTA welcomes positive developments but regrets missed opportunities to support plasma donors and patients who rely on plasma-derived medicinal products (PDMPs)
All
PPTA statements
No results found